Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06370481 · ClinicalTrials.gov registry record · NA

HIV, Equity, and Addiction Training (HEAT) Program

A NA study of HIV and Opioid Use Disorder, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06370481 is a NA study of HIV and Opioid Use Disorder that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06370481, a NA study of HIV and Opioid Use Disorder, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This project is a pilot study to determine the feasibility and acceptability of a telemedicine intervention for substance use disorder service delivery in diverse people living with HIV in Alabama.

Interventions

  • OTHER Standard of care
  • OTHER Telemedicine

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-01-29
Est. Completion 2029-06
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT06370481

The ClinicalTrials.gov registry entry for NCT06370481 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (93% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.

NCT06370481 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06370481 about?

NCT06370481 is a clinical study titled "HIV, Equity, and Addiction Training (HEAT) Program". This project is a pilot study to determine the feasibility and acceptability of a telemedicine intervention for substance use disorder service delivery in diverse people living with HIV in Alabama.

What is the current status of trial NCT06370481?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-01-29. Estimated completion is 2029-06.

What conditions does trial NCT06370481 study?

This clinical trial studies the following conditions: HIV, Opioid Use Disorder, Substance Use Disorders, Stimulant Use (Diagnosis).

What interventions are being tested in trial NCT06370481?

The interventions under investigation include: Standard of care (OTHER), Telemedicine (OTHER).

Who is sponsoring clinical trial NCT06370481?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06370481 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.